US Stock MarketDetailed Quotes

ADXN Addex Therapeutics

Watchlist
  • 8.7900
  • 0.00000.00%
Close May 17 16:00 ET
9.39MMarket Cap-475P/E (TTM)

About Addex Therapeutics Company

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Company Profile

SymbolADXN
Company NameAddex Therapeutics
Listing DateJan 29, 2020
Founded2002
CEOMr. Tim Dyer
MarketNASDAQ
Employees23
Securities TypeDR
ADS Ratio1.0 : 120.0
Fiscal Year Ends12-31
Address9, Chemin des Mines,Plan-les-Ouates
CityGeneva
ProvinceGeneve (Geneva)
CountrySwitzerland
Zip Code1202
Phone41-22-884-15-55

Company Executives

  • Name
  • Position
  • Salary
  • Tim Dyer
  • Chief Executive Officer and Director
  • --
  • Dr. Roger M. Mills,M.D.
  • Chief Medical Officer and Director
  • --
  • Vincent Lawton
  • Chairman of the Board
  • 155.75K
  • Raymond Hill
  • Director
  • 89.65K
  • Jake R. Nunn
  • Independent Director
  • 41.29K
  • Dr. Isaac Manke
  • Independent Director
  • 41.29K
  • Robert Lütjens
  • Head of Discovery, Biology
  • --
  • Lénaic Teyssédou
  • Head of Finance
  • --
  • Jean-Philippe Rocher
  • Head of Discovery, Chemistry
  • --
  • Dr. Mikhail Kalinichev
  • Head of Translational science
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg